Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.

Leukemia - 1 Apr 2010

Wang S A, Jabbar K, Lu G, Chen S S, Galili N, Vega F, Jones D, Raza A, Kantarjian H, Garcia-Manero G, McDonnell T J, Medeiros L J

Abstract excerpt

Trisomy 11 in myelodysplastic syndromes (MDS) is rare, with undefined clinical significance and is currently assigned to the International Prognostic Scoring System (IPSS) intermediate-risk group. Over a 15-year period, we identified 17 MDS patients with trisomy 11 either as a sole abnormality (n...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Disorders
Share to Chromosomes, Human, Pair 11
Share to fms-Like Tyrosine Kinase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Duplication

Share to Histone-Lysine N-Methyltransferase

Share to Myelodysplastic Syndromes

Share to Myeloid-Lymphoid Leukemia Protein

Share to Trisomy

Source

Identifiers

PMID: 20072149
DOI: 10.1038/leu.2009.289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20072149-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.PMID 20072149Read ↗

Trisomy 11: an association with stem/progenitor cell immunophenotype.Semantic proximity Read ↗

Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression.Semantic proximity Read ↗

Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.Semantic proximity Read ↗

Trisomy 8 in acute myeloid leukemiaSemantic proximity Read ↗

Autoimmune Features in Myelodysplastic Syndromes: Clinical and Molecular Heterogeneity With Integrated IPSS-M Analysis.Semantic proximity Read ↗

Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromesSemantic proximity Read ↗

Mutational Profile Enables the Identification of a High Risk Subgroup in Myelodysplastic Syndromes With Isolated Trisomy 8Semantic proximity Read ↗

Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromesSemantic proximity Read ↗

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8Semantic proximity Read ↗

Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patientsSemantic proximity Read ↗

Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromesSemantic proximity Read ↗

Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.